FAQ

DOTA-Tyr(1)-octreotate

Known as: DOTA-1-Tyr-octreotate, DOTA-1-tyrosyl-octreotate, DOTA-Y1-TATE 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2018
01220012018

Related topics

Related topics

4 relations

Narrower (1)

DOTA-D-Tyr(1)-octreotate

Broader (2)

Heterocyclic Compounds, 1-RingOctreotide
analogs & derivatives

Related mentions per year

Related mentions per year

1954-2018
1960198020002020
DOTA-Tyr(1)-octreotate
Octreotide
Heterocyclic Compounds, 1-Ring
analogs & derivatives
DOTA-D-Tyr(1)-octreotate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Potentiation of 177Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitor
For patients with inoperable neuroendocrine tumors (NETs) expressing somatostatin receptors, peptide receptor radionuclide… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2017
2017
Comparing the use of radiolabeled SSTR agonists and an SSTR antagonist in breast cancer: does the model choice influence the outcome?
* Correspondence: s.dalm@erasmusmc.nl Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, South Holland… (More)
  • figure 1
Is this relevant?
2016
2016
Radiosynthesis and Preclinical Evaluation of 18F-Fluoroglycosylated Octreotate for Somatostatin Receptor Imaging.
Short synthetic octapeptide analogs derived from the native somatostatin peptides SST-14 and SST-28, namely, octreotate (TATE) or… (More)
Is this relevant?
2015
2015
Cyclotron production of 43Sc for PET imaging
BACKGROUND Recently, significant interest in (44)Sc as a tracer for positron emission tomography (PET) imaging has been observed… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2015
2015
Optimization of combined temozolomide and peptide receptor radionuclide therapy (PRRT) in mice after multimodality molecular imaging studies
BACKGROUND Successful treatments of patients with somatostatin receptor (SSTR)-overexpressing neuroendocrine tumours (NET… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2014
2014
Preclinical evaluation of a high-affinity 18F-trifluoroborate octreotate derivative for somatostatin receptor imaging.
UNLABELLED Recent studies have highlighted the high sensitivity of PET imaging with (68)Ga-labeled octreotide derivatives for the… (More)
Is this relevant?
2007
2007
From outside to inside? Dose-dependent renal tubular damage after high-dose peptide receptor radionuclide therapy in rats measured with in vivo (99m)Tc-DMSA-SPECT and molecular imaging.
UNLABELLED In peptide receptor radionuclide therapy (PRRT), the dose-limiting organ is, most often, the kidney. However, the… (More)
Is this relevant?
2002
2002
Fluorescent somatostatin receptor probes for the intraoperative detection of tumor tissue with long-wavelength visible light.
Targeted fluorescent dyes are of substantial value for the intraoperative delineation of primary tumors and metastatic lesions… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands
We report here the in vivo diagnostic use of a peptide–dye conjugate consisting of a cyanine dye and the somatostatin analog… (More)
  • figure 3
  • figure 2
  • figure 5
  • figure 4
  • figure 6
Is this relevant?
Highly Cited
2001
Highly Cited
2001
[177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy.
Receptor-targeted scintigraphy using radiolabeled somatostatin analogs such as octreotate is being used with great success to… (More)
Is this relevant?